Literature DB >> 18565876

Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.

Frederick R Appelbaum.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18565876     DOI: 10.1200/JCO.2007.15.7479

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.

Authors:  Bing Bai; Hui-Qiang Huang; Qing-Qing Cai; Xiao-Xiao Wang; Qi-Chun Cai; Ze-Xiao Lin; Yan Gao; Yi Xia; Qing Bu; Ying Guo
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

2.  Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS.

Authors:  Atul Sharma; Smita Kayal; Sobuhi Iqbal; Prabhat Singh Malik; Vinod Raina
Journal:  Springerplus       Date:  2013-09-26

Review 3.  Treatment challenges in the management of relapsed or refractory non-Hodgkin's lymphoma - novel and emerging therapies.

Authors:  Mark P Chao
Journal:  Cancer Manag Res       Date:  2013-08-23       Impact factor: 3.989

4.  Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.

Authors:  Yan-Li Li; Kang-Sheng Gu; Yue-Yin Pan; Yang Jiao; Zhi-Min Zhai
Journal:  BMC Cancer       Date:  2014-05-19       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.